Time-of-Flight Mass Spectrometry Versus Orbitrap-Based Mass Spectrometry for the Screening and Identification of Drugs and Metabolites: Is There a Winner?

Comprehensive Analytical Chemistry

Volumn 58, Issue , 2012, Pages 217-272

  Eichhorn, Peter ^a   Pérez, Sandra ^a   Barceló, Damià ^a  

^a INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

Author keywords

Doping control; Drug metabolism; Environmental analysis; Food analysis; Forensic toxicology; Metabolites; Orbitrap MS; Pharmaceuticals; Time of flight MS; Transformation products

Indexed keywords

EID: 84863863406     PISSN: 0166526X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53810-9.00009-2     Document Type: Chapter

References (99)

1. Makarov A., Denisov E., et al. Performance evaluation of a hybrid linear ion trap/orbitrap mass spectrometer. Anal Chem 2006, 78(7):2113-2120.
2. Makarov A., Denisov E., et al. Dynamic range of mass accuracy in LTQ Orbitrap hybrid mass spectrometer. J Am Soc Mass Spectrom 2006, 17(7):977-982.
3. Makarov A., Muenster H. Breakthrough technology for bottom-up proteomics and small molecule research. Am Lab 2006, 38(14):32-34.
4. Scigelova M., Makarov A. Orbitrap mass analyzer-overview and applications in proteomics. Proteomics 2006, (6 Suppl. 1):16-21.
5. Scigelova M., Makarov A. Advances in bioanalytical LC-MS using the Orbitrap™ mass analyzer. Bioanalysis 2009, 1(4):741-754.
6. Geiger T., Cox J., et al. Proteomics on an orbitrap benchtop mass spectrometer using all-ion fragmentation. Mol Cell Proteomics 2010, 9(10):2252-2261.
7. Moulard Y., Bailly-Chouriberry L., et al. Use of benchtop exactive high resolution and high mass accuracy orbitrap mass spectrometer for screening in horse doping control. Anal Chim Acta 2011, 700(1-2):126-136.
8. Wong R.L., Xin B., et al. Optimization of exactive Orbitrap™ acquisition parameters for quantitative bioanalysis. Bioanalysis 2011, 3(8):863-871.
9. Perry R.H., Cooks R.G., et al. Orbitrap mass spectrometry: instrumentation, ion motion and applications. Mass Spectrom Rev 2008, 27(6):661-699.
10. Jiwan J.L.H., Wallemacq P., et al. HPLC-high resolution mass spectrometry in clinical laboratory?. Clin Biochem 2011, 44(1):136-147.
11. Makarov A., Scigelova M. Coupling liquid chromatography to Orbitrap mass spectrometry. J Chromatogr A 2010, 1217(25):3938-3945.
12. Chernushevich I.V., Loboda A.V., et al. An introduction to quadrupole-time-of-flight mass spectrometry. J Mass Spectrom 2001, 36(8):849-865.
13. Erve J.C.L., DeMaio W., et al. Rapid metabolite identification with sub parts-permillion mass accuracy from biological matrices by direct infusion nanoelectrospray ionization after clean-up on a ZipTip and LTQ/Orbitrap mass spectrometry. Rapid Commun Mass Spectrom 2008, 22(19):3015-3026.
14. Xu Y., Heilier J.F., et al. Evaluation of accurate mass and relative isotopic abundance measurements in the LTQ-Orbitrap mass spectrometer for further metabolomics database building. Anal Chem 2010, 82(13):5490-5501.
15. AGILENT. Agilent 6540 UHD Q-TOF produces more accurate isotope ratios than Thermo LTQ Orbitrap XL. Application note; 2009.
16. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 1999, 107(Suppl. 6):907-938.
17. Hirsch R., Ternes T., et al. Occurrence of antibiotics in the aquatic environment. Sci Total Environ 1999, 225(1-2):109-118.
18. Carballa M., Omil F., et al. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 2004, 38(12):2918-2926.
19. Oulton R.L., Kohn T., et al. Pharmaceuticals and personal care products in effluent matrices: a survey of transformation and removal during wastewater treatment and implications for wastewater management. J Environ Monit 2010, 12(11):1956-1978.
20. Ternes T.A., Joss A., et al. Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environ Sci Technol 2004, 38(20):392A-399A.
21. Farré M.l., Pérez S., et al. Fate and toxicity of emerging pollutants, their metabolites and transformation products in the aquatic environment. Trends Anal Chem 2008, 27(11):991-1007.
22. Pérez S., Barceló D. Applications of LC-MS to quantitation and evaluation of the environmental fate of chiral drugs and their metabolites. Trends Anal Chem 2008, 27(10):836-846.
23. Pérez S., Eichhorn P., et al. Structural characterization of metabolites of the X-ray contrast agent iopromide in activated sludge using ion trap mass spectrometry. Anal Chem 2006, 78(6):1866-1874.
24. Pérez S., Eichhorn P., et al. Elucidation of phototransformation reactions of the X-ray contrast medium iopromide under simulated solar radiation using UPLC-ESI-QqTOF-MS. J Mass Spectrom 2009, 44(9):1308-1317.
25. Gebhardt W., Schröder H.F. Liquid chromatography-(tandem) mass spectrometry for the follow-up of the elimination of persistent pharmaceuticals during wastewater treatment applying biological wastewater treatment and advanced oxidation. J Chromatogr A 2007, 1160(1-2):34-43.
26. Gros M., Petrovié M., et al. Multi-residue analytical methods using LC-tandem MS for the determination of pharmaceuticals in environmental and wastewater samples: a review. Anal Bioanal Chem 2006, 386(4):941-952.
27. Petrovic M., Farré M., et al. Recent trends in the liquid chromatography-mass spectrometry analysis of organic contaminants in environmental samples. J Chromatogr A 2010, 1217(25):4004-4017.
28. Hogenboom A.C., van Leerdam J.A., et al. Accurate mass screening and identification of emerging contaminants in environmental samples by liquid chromatography-hybrid linear ion trap Orbitrap mass spectrometry. J Chromatogr A 2009, 1216(3):510-519.
29. Schriks M., Van Leerdam J.A., et al. High-resolution mass spectrometric identification and quantification of glucocorticoid compounds in various wastewaters in the Netherlands. Environ Sci Technol 2010, 44(12):4766-4774.
30. Kern S., Fenner K., et al. Identification of transformation products of organic contaminants in natural waters by computer-aided prediction and high-resolution mass spectrometry. Environ Sci Technol 2009, 43(18):7039-7046.
31. Herrera Rivera Z., Oosterink E., et al. Influence of natural organic matter on the screening of pharmaceuticals in water by using liquid chromatography with full scan mass spectrometry. Anal Chim Acta 2011, 700(1-2):114-125.
32. Ibáñez M., Guerrero C., et al. Screening of antibiotics in surface and wastewater samples by ultra-high-pressure liquid chromatography coupled to hybrid quadrupole time-of-flight mass spectrometry. J Chromatogr A 2009, 1216(12):2529-2539.
33. Hernández F., Bijlsma L., et al. Rapid wide-scope screening of drugs of abuse, prescription drugs with potential for abuse and their metabolites in influent and effluent urban wastewater by ultrahigh pressure liquid chromatography-quadrupole-time-of-flight-mass spectrometry. Anal Chim Acta 2011, 684(1-2):87-97.
34. Gómez M.J., Gómez-Ramos M.M., et al. Rapid automated screening, identification and quantification of organic micro-contaminants and their main transformation products in wastewater and river waters using liquid chromatography-quadrupole-time-of-flight mass spectrometry with an accurate-mass database. J Chromatogr A 2010, 1217(45):7038-7054.
35. Ferrer I., Thurman E.M., et al. Analysis of environmental samples with ultra high definition LC-QToF-MS and accurate mass: how much resolving power is enough? 2010, Agilent, Santa Clara, CA (USA), Application note.
36. Ferrer I., Thurman E.M. Identification of a new antidepressant and its glucuronide metabolite in water samples using liquid chromatography/quadrupole time-of-flight mass spectrometry. Anal Chem 2010, 82(19):8161-8168.
37. Terzic S., Ahel M. Nontarget analysis of polar contaminants in freshwater sediments influenced by pharmaceutical industry using ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. Environ Pollut 2011, 159(2):557-566.
38. Helbling D.E., Hollender J., et al. High-throughput identification of microbial transformation products of organic micropollutants. Environ Sci Technol 2010, 44(17):6621-6627.
39. Prasse C., Wagner M., et al. Biotransformation of the antiviral drugs acyclovir and penciclovir in activated sludge treatment. Environ Sci Technol 2011, 45(7):2761-2769.
40. Pérez-Parada A., Agüera A., et al. Behavior of amoxicillin in wastewater and river water: identification of its main transformation products by liquid chromatography/electrospray quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2011, 25(6):731-742.
41. De Brabander H.F., Le Bizec B., et al. Past, present and future of mass spectrometry in the analysis of residues of banned substances in meat-producing animals. J Mass Spectrom 2007, 42(8):983-998.
42. Malik A.K., Blasco C., et al. Liquid chromatography-mass spectrometry in food safety. J Chromatogr A 2010, 1217(25):4018-4040.
43. Núñez O., Moyano E., et al. LC-MS/MS analysis of organic toxics in food. Trends Anal Chem 2005, 24(7):683-703.
44. Nielen M.W.F., van Engelen M.C., et al. Screening and confirmation criteria for hormone residue analysis using liquid chromatography accurate mass time-of-flight, Fourier transform ion cyclotron resonance and orbitrap mass spectrometry techniques. Anal Chim Acta 2007, 586(1-2 Spec. Issue):122-129.
45. Huang J.F., Zhang H.J., et al. Multiresidue analysis of β-agonists in pork by coupling polymer monolith microextraction to electrospray quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2007, 21(17):2895-2904.
46. Kaufmann A., Butcher P., et al. Quantitative multiresidue method for about 100 veterinary drugs in different meat matrices by sub 2-μm particulate high-performance liquid chromatography coupled to time of flight mass spectrometry. J Chromatogr A 2008, 1194(1):66-79.
47. Kaufmann A., Butcher P., et al. Development of an improved high resolution mass spectrometry based multi-residue method for veterinary drugs in various food matrices. Anal Chim Acta 2011, 700(1-2):86-94.
48. Kaufmann A., Butcher P., et al. Quantitative and confirmative performance of liquid chromatography coupled to high-resolution mass spectrometry compared to tandem mass spectrometry. Rapid Commun Mass Spectrom 2011, 25(7):979-992.
49. Kaufmann A., Butcher P., et al. Comprehensive comparison of liquid chromatography selectivity as provided by two types of liquid chromatography detectors (high resolution mass spectrometry and tandem mass spectrometry): "Where is the crossover point"? Anal Chim Acta 2010, 673(1):60-72.
50. Peters R.J.B., Bolck Y.J.C., et al. Multi-residue screening of veterinary drugs in egg, fish and meat using high-resolution liquid chromatography accurate mass time-of-flight mass spectrometry. J Chromatogr A 2009, 1216(46):8206-8216.
51. Peters R.J.B., Van Engelen M.C., et al. Searching for in silico predicted metabolites and designer modifications of (cortico)steroids in urine by high-resolution liquid chromatography/time-of- flight mass spectrometry. Rapid Commun Mass Spectrom 2009, 23(15):2329-2337.
52. Zheng M.M., Ruan G.D., et al. Evaluating polymer monolith in-tube solid-phase microextraction coupled to liquid chromatography/quadrupole time-of-flight mass spectrometry for reliable quantification and confirmation of quinolone antibacterials in edible animal food. J Chromatogr A 2009, 1216(44):7510-7519.
53. Ortelli D., Cognard E., et al. Comprehensive fast multiresidue screening of 150 veterinary drugs in milk by ultra-performance liquid chromatography coupled to time of flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877(23):2363-2374.
54. Turnipseed S.B., Storey J.M., et al. Analysis of veterinary drugs and metabolites in milk using quadrupole time-of-flight liquid chromatography-mass spectrometry. J Agric Food Chem 2011, 59:7569-7581.
55. Kellmann M., Muenster H., et al. Full scan MS in comprehensive qualitative and quantitative residue analysis in food and feed matrices: how much resolving power is required?. J Am Soc Mass Spectrom 2009, 20(8):1464-1476.
56. van der Heeft E., Bolck Y.J.C., et al. Full-scan accurate mass selectivity of ultra-performance liquid chromatography combined with time-of-flight and orbitrap mass spectrometry in hormone and veterinary drug residue analysis. J Am Soc Mass Spectrom 2009, 20(3):451-463.
57. Benedetti M.S., Whomsley R., et al. Drug metabolism and pharmacokinetics. Drug Metab Rev 2009, 41(3):344-390.
58. Lin J., Sahakian D.C., et al. The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery. Curr Top Med Chem 2003, 3(10):1125-1154.
59. Yengi L.G., Leung L., et al. The evolving role of drug metabolism in drug discovery and development. Pharm Res 2007, 24(5):842-858.
60. Liang Y., Wang G., et al. Recent development in liquid chromatography/mass spectrometry and emerging technologies for metabolite identification. Curr Drug Metab 2011, 12(4):329-344.
61. Tolonen A., Turpeinen M., et al. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening. Drug Discov Today 2009, 14(3-4):120-133.
62. Hewitt N.J., Lechón M.J.G., et al. Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 2007, 39(1):159-234.
63. Testa B., Krämer S.D. The biochemistry of drug metabolism-an introduction: part 1. Principles and overview. Chem Biodivers 2006, 3(10):1053-1101.
64. Peterman S.M., Duczak N., et al. Application of a linear ion trap/orbitrap mass spectrometer in metabolite characterization studies: examination of the human liver microsomal metabolism of the non-tricyclic anti-depressant nefazodone using data-dependent accurate mass measurements. J Am Soc Mass Spectrom 2006, 17(3):363-375.
65. Li A.C., Shou W.Z., et al. Complete profiling and characterization of in vitro nefazodone metabolites using two different tandem mass spectrometric platforms. Rapid Commun Mass Spectrom 2007, 21(24):4001-4008.
66. Li A.C., Ding J., et al. Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification. Rapid Commun Mass Spectrom 2009, 23(18):3003-3012.
67. Ruan Q., Peterman S., et al. An integrated method for metabolite detection and identification using a linear ion trap/Orbitrap mass spectrometer and multiple data processing techniques: application to indinavir metabolite detection. J Mass Spectrom 2008, 43(2):251-261.
68. Chen G., Daaro I., et al. Structural characterization of in vitro rat liver microsomal metabolites of antihistamine desloratadine using LTQ-Orbitrap hybrid mass spectrometer in combination with online hydrogen/deuterium exchange HR-LC/MS. J Mass Spectrom 2009, 44(2):203-213.
69. Lim H.K., Chen J., et al. A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry. Rapid Commun Mass Spectrom 2008, 22(8):1295-1311.
70. Rousu T., Herttuainen J., et al. Comparison of triple quadrupole, hybrid linear ion trap triple quadrupole, time-of-flight and LTQ-orbitrap mass spectrometers in drug discovery phase metabolite screening and identification in vitro-amitriptyline and verapamil as model compounds. Rapid Commun Mass Spectrom 2010, 24(7):939-957.
71. Liu Z., Huang L., et al. Metabolism of olaquindox in rat liver microsomes: structural elucidation of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2008, 22(7):1009-1016.
72. Liu Z.Y., Tao Y.F., et al. Identification of carbadox metabolites formed by liver microsomes from rats, pigs and chickens using high-performance liquid chromatography combined with hybrid ion trap/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2011, 25(2):341-348.
73. Tiller P.R., Yu S., et al. Fractional mass filtering as a means to assess circulating metabolites in early human clinical studies. Rapid Commun Mass Spectrom 2008, 22(22):3510-3516.
74. Bonn B., Leandersson C., et al. Enhanced metabolite identification with MSE and a semiautomated software for structural elucidation. Rapid Commun Mass Spectrom 2010, 24(21):3127-3138.
75. Mortishire-Smith R.J., Castro-Perez J.M., et al. Generic dealkylation: a tool for increasing the hit-rate of metabolite rationalization, and automatic customization of mass defect filters. Rapid Commun Mass Spectrom 2009, 23(7):939-948.
76. Dear G.J., Munoz-Muriedas J., et al. Sites of metabolic substitution: investigating metabolite structures utilising ion mobility and molecular modelling. Rapid Commun Mass Spectrom 2010, 24(21):3157-3162.
77. Chan E.C.Y., Lee S.N., et al. Pharmaceutical metabolite profiling using quadrupole/ion mobility spectrometry/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2009, 23(3):384-394.
78. Zhang H., Zhu M., et al. Mass defect profiles of biological matrices and the general applicability of mass defect filtering for metabolite detection. Rapid Commun Mass Spectrom 2008, 22(13):2082-2088.
79. Zhu M., Ma L., et al. Detection and characterization of metabolites in biological matrices using mass defect filtering of liquid chromatography/high resolution mass spectrometry data. Drug Metab Dispos 2006, 34(10):1722-1733.
80. Lim H.K., Chen J., et al. Metabolite identification by data-dependent accurate mass spectrometric analysis at resolving power of 60 000 in external calibration mode using an LTQ/Orbitrap. Rapid Commun Mass Spectrom 2007, 21(12):1821-1832.
81. Giles K., Wildgoose J.L., et al. A method for direct measurement of ion mobilities using a travelling wave ion guide. Int J Mass Spectrom 2010, 298(1-3):10-16.
82. Pringle S.D., Giles K., et al. An investigation of the mobility separation of some peptide and protein ions using a new hybrid quadrupole/travelling wave IMS/oa-ToF instrument. Int J Mass Spectrom 2007, 261(1):1-12.
83. Peters F.T. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin Biochem 2011, 44(1):54-65.
84. Thevis M., Schänzer W. Current role of LC-MS(/MS) in doping control. Anal Bioanal Chem 2007, 388(7):1351-1358.
85. Thevis M., Thomas A., et al. Current role of LC-MS(/MS) in doping control. Anal Bioanal Chem 2011, 401(2):405-420.
86. Ojanperä S., Pelander A., et al. Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2006, 20(7):1161-1167.
87. Badoud F., Grata E., et al. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography-quadrupole time-of-flight mass spectrometry. II: confirmatory analysis. J Chromatogr A 2010, 1217(25):4109-4119.
88. Vonaparti A., Lyris E., et al. Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2010, 24(11):1595-1609.
89. Virus E.D., Sobolevsky T.G., et al. Introduction of HPLC/orbitrap mass spectrometry as screening method for doping control. J Mass Spectrom 2008, 43(7):949-957.
90. Thomas A., Guddat S., et al. Comprehensive plasma-screening for known and unknown substances in doping controls. Rapid Commun Mass Spectrom 2010, 24(8):1124-1132.
91. Broecker S., Herre S., et al. Development and practical application of a library of CID accurate mass spectra of more than 2,500 toxic compounds for systematic toxicological analysis by LC-QTOF-MS with data-dependent acquisition. Anal Bioanal Chem 2011, 400(1):101-117.
92. Liotta E., Gottardo R., et al. Screening for pharmaco-toxicologically relevant compounds in biosamples using high-resolution mass spectrometry: a 'metabolomic' approach to the discrimination between isomers. J Mass Spectrom 2010, 45(3):261-271.
93. Kolmonen M., Leinonen A., et al. A general screening method for doping agents in human urine by solid phase extraction and liquid chromatography/time-of-flight mass spectrometry. Anal Chim Acta 2007, 585(1):94-102.
94. Pozo O.J., Van Eenoo P., et al. Comparison between triple quadrupole, time of flight and hybrid quadrupole time of flight analysers coupled to liquid chromatography for the detection of anabolic steroids in doping control analysis. Anal Chim Acta 2011, 684(1-2):98-111.
95. Zhang N.R., Yu S., et al. Quantitation of small molecules using high-resolution accurate mass spectrometers-a different approach for analysis of biological samples. Rapid Commun Mass Spectrom 2009, 23(7):1085-1094.
96. Pelander A., Tyrkkö E., et al. In silico methods for predicting metabolism and mass fragmentation applied to quetiapine in liquid chromatography/time-of-flight mass spectrometry urine drug screening. Rapid Commun Mass Spectrom 2009, 23(4):506-514.
97. Nielsen M.K.K., Johansen S.S., et al. Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS. Forensic Sci Int 2010, 196(1-3):85-92.
98. Kellersberger K.A., Pelander A., et al. Evalution of performance and benefit of ultrahigh-resolution ESI-ToF-MS coupled to fast chromatography in the application of forensic screening. ASMS 2010.
99. Pelander A., Decker P., et al. Evaluation of a high resolving power time-of-flight mass spectrometer for drug analysis in terms of resolving power and acquisition rate. J Am Soc Mass Spectrom 2011, 22(2):379-385.